Kathleen McLean

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

JA Millar, FH Derkx, Kathleen McLean et al. · British Journal of Clinical Pharmacology · 1982 · 120 citations · Full text

Medicine, Endocrinology, Pharmacology +10

Noradrenaline release and clearance in relation to age and blood pressure in man

Peter C. Rubin, P. J. Scott, Kathleen McLean et al. · European Journal of Clinical Investigation · 1982 · 89 citations

Pharmacy, Geriatric Medicine, Pharmacology +10

A pharmacodynamic and pharmacokinetic assessment of a new alpha‐ adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.

HL Elliott, PA Meredith, DJ Sumner et al. · British Journal of Clinical Pharmacology · 1982 · 87 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Effect of Age on the Responsiveness of Vascular α-Adrenoceptors in Man

Henry L. Elliott, D. J. Sumner, Kathleen McLean et al. · Journal of Cardiovascular Pharmacology · 1982 · 81 citations

Medicine, Cardiology, Pharmacology +17

Wnt5a Exhibits Layer-Specific Expression in Adult Skin, Is Upregulated in Psoriasis, and Synergizes with Type 1 Interferon

Małgorzata Romanowska, Alan Evans, D J Kellock et al. · PLoS ONE · 2009 · 67 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +15